Global Glutamate Receptor Ionotropic NMDA 2B Market Insights, Forecast to 2029

The global Glutamate Receptor Ionotropic NMDA 2B market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Glutamate Receptor Ionotropic NMDA 2B, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Glutamate Receptor Ionotropic NMDA 2B, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Glutamate Receptor Ionotropic NMDA 2B, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glutamate Receptor Ionotropic NMDA 2B sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Glutamate Receptor Ionotropic NMDA 2B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Glutamate Receptor Ionotropic NMDA 2B sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc.

1.1 Glutamate Receptor Ionotropic NMDA 2B Product Introduction

1.2 Market by Type

1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 JNJ-0808

1.2.3 Neu-2000

1.2.4 NP-10679

1.2.5 NP-11948

1.2.6 Radiprodil

1.2.7 Others

1.3 Market by Application

1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Acute Ischemic Stroke

1.3.3 Autism

1.3.4 Brain Ischemia

1.3.5 Burns

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Estimates and Forecasts 2018-2029

2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region

2.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2023)

2.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2024-2029)

2.2.4 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2018-2029)

2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Estimates and Forecasts 2018-2029

2.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region

2.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2023)

2.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2029)

2.4.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers

3.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (2018-2023)

3.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glutamate Receptor Ionotropic NMDA 2B in 2022

3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers

3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2018-2023)

3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Glutamate Receptor Ionotropic NMDA 2B Revenue in 2022

3.3 Global Key Players of Glutamate Receptor Ionotropic NMDA 2B, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Offered and Application

3.8 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type

4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Historical Sales by Type (2018-2023)

4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Sales by Type (2024-2029)

4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type

4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Historical Revenue by Type (2018-2023)

4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Revenue by Type (2024-2029)

4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

4.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type

4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2018-2023)

4.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Type (2024-2029)

5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application

5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Historical Sales by Application (2018-2023)

5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Sales by Application (2024-2029)

5.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application

5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Historical Revenue by Application (2018-2023)

5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Forecasted Revenue by Application (2024-2029)

5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application

5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2018-2023)

5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Application (2024-2029)

6.1 US & Canada Glutamate Receptor Ionotropic NMDA 2B Market Size by Type

6.1.1 US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2029)

6.1.2 US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2029)

6.2 US & Canada Glutamate Receptor Ionotropic NMDA 2B Market Size by Application

6.2.1 US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2029)

6.2.2 US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2029)

6.3 US & Canada Glutamate Receptor Ionotropic NMDA 2B Market Size by Country

6.3.1 US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2029)

6.3.3 US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Type

7.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2029)

7.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2029)

7.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Application

7.2.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2029)

7.2.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2029)

7.3 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country

7.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2029)

7.3.3 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8.1 China Glutamate Receptor Ionotropic NMDA 2B Market Size

8.1.1 China Glutamate Receptor Ionotropic NMDA 2B Sales (2018-2029)

8.1.2 China Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029)

8.2 China Glutamate Receptor Ionotropic NMDA 2B Market Size by Application

8.2.1 China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2029)

8.2.2 China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2029)

9.1 Asia Glutamate Receptor Ionotropic NMDA 2B Market Size by Type

9.1.1 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2029)

9.1.2 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2029)

9.2 Asia Glutamate Receptor Ionotropic NMDA 2B Market Size by Application

9.2.1 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2029)

9.2.2 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2029)

9.3 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Region

9.3.1 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2029)

9.3.3 Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10.1 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Type

10.1.1 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Application

10.2.1 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country

10.3.1 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11.1 BioCrea GmbH

11.1.1 BioCrea GmbH Company Information

11.1.2 BioCrea GmbH Overview

11.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 BioCrea GmbH Recent Developments

11.2 Bristol-Myers Squibb Company

11.2.1 Bristol-Myers Squibb Company Company Information

11.2.2 Bristol-Myers Squibb Company Overview

11.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Bristol-Myers Squibb Company Recent Developments

11.3 Cerecor Inc.

11.3.1 Cerecor Inc. Company Information

11.3.2 Cerecor Inc. Overview

11.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Cerecor Inc. Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Overview

11.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Johnson & Johnson Recent Developments

11.5 Luc Therapeutics, Inc.

11.5.1 Luc Therapeutics, Inc. Company Information

11.5.2 Luc Therapeutics, Inc. Overview

11.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Luc Therapeutics, Inc. Recent Developments

11.6 NeurOp, Inc

11.6.1 NeurOp, Inc Company Information

11.6.2 NeurOp, Inc Overview

11.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 NeurOp, Inc Recent Developments

11.7 Novartis AG

11.7.1 Novartis AG Company Information

11.7.2 Novartis AG Overview

11.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Novartis AG Recent Developments

11.8 UCB S.A.

11.8.1 UCB S.A. Company Information

11.8.2 UCB S.A. Overview

11.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 UCB S.A. Recent Developments

12.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis

12.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process

12.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing

12.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels

12.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors

12.5 Glutamate Receptor Ionotropic NMDA 2B Customers

13.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends

13.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers

13.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges

13.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of JNJ-0808

    Table 3. Major Manufacturers of Neu-2000

    Table 4. Major Manufacturers of NP-10679

    Table 5. Major Manufacturers of NP-11948

    Table 6. Major Manufacturers of Radiprodil

    Table 7. Major Manufacturers of Others

    Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2023) & (US$ Million)

    Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2024-2029) & (US$ Million)

    Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2018-2023)

    Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2024-2029)

    Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2023) & (K Pcs)

    Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2029) & (K Pcs)

    Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2018-2023)

    Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2024-2029)

    Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers (2018-2023) & (K Pcs)

    Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Manufacturers (2018-2023)

    Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers (2018-2023)

    Table 23. Global Key Players of Glutamate Receptor Ionotropic NMDA 2B, Industry Ranking, 2021 VS 2022 VS 2023

    Table 24. Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturers 2018-2023 (USD/Pcs)

    Table 25. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 26. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2022)

    Table 27. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Base Distribution and Headquarters

    Table 28. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Offered and Application

    Table 29. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Date of Enter into This Industry

    Table 30. Mergers & Acquisitions, Expansion Plans

    Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2018-2023)

    Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Type (2024-2029)

    Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 37. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2018-2023)

    Table 38. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Type (2024-2029)

    Table 39. Glutamate Receptor Ionotropic NMDA 2B Price by Type (2018-2023) & (USD/Pcs)

    Table 40. Global Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Type (2024-2029) & (USD/Pcs)

    Table 41. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2018-2023)

    Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Application (2024-2029)

    Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2018-2023)

    Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Application (2024-2029)

    Table 49. Glutamate Receptor Ionotropic NMDA 2B Price by Application (2018-2023) & (USD/Pcs)

    Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Price Forecast by Application (2024-2029) & (USD/Pcs)

    Table 51. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 52. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 53. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 54. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 55. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 56. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 57. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 58. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 59. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 60. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2023) & (US$ Million)

    Table 61. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2029) & (US$ Million)

    Table 62. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2023) & (K Pcs)

    Table 63. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2029) & (K Pcs)

    Table 64. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 65. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 66. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 67. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 68. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 69. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 70. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 71. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 72. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 73. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2023) & (US$ Million)

    Table 74. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2029) & (US$ Million)

    Table 75. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2023) & (K Pcs)

    Table 76. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2029) & (K Pcs)

    Table 77. China Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 78. China Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 79. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 80. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 81. China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 82. China Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 83. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 84. China Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 85. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 86. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 87. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 88. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 89. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 90. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 91. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 92. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 93. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 94. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2023) & (US$ Million)

    Table 95. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2024-2029) & (US$ Million)

    Table 96. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2023) & (K Pcs)

    Table 97. Asia Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2029) & (K Pcs)

    Table 98. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2023) & (K Pcs)

    Table 99. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2029) & (K Pcs)

    Table 100. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2023) & (US$ Million)

    Table 101. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2029) & (US$ Million)

    Table 102. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2023) & (K Pcs)

    Table 103. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2029) & (K Pcs)

    Table 104. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2023) & (US$ Million)

    Table 105. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2029) & (US$ Million)

    Table 106. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 107. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2023) & (US$ Million)

    Table 108. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2029) & (US$ Million)

    Table 109. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2023) & (K Pcs)

    Table 110. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2029) & (K Pcs)

    Table 111. BioCrea GmbH Company Information

    Table 112. BioCrea GmbH Description and Major Businesses

    Table 113. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 114. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 115. BioCrea GmbH Recent Developments

    Table 116. Bristol-Myers Squibb Company Company Information

    Table 117. Bristol-Myers Squibb Company Description and Major Businesses

    Table 118. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 119. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 120. Bristol-Myers Squibb Company Recent Developments

    Table 121. Cerecor Inc. Company Information

    Table 122. Cerecor Inc. Description and Major Businesses

    Table 123. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 124. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 125. Cerecor Inc. Recent Developments

    Table 126. Johnson & Johnson Company Information

    Table 127. Johnson & Johnson Description and Major Businesses

    Table 128. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 129. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 130. Johnson & Johnson Recent Developments

    Table 131. Luc Therapeutics, Inc. Company Information

    Table 132. Luc Therapeutics, Inc. Description and Major Businesses

    Table 133. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 134. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 135. Luc Therapeutics, Inc. Recent Developments

    Table 136. NeurOp, Inc Company Information

    Table 137. NeurOp, Inc Description and Major Businesses

    Table 138. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 139. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 140. NeurOp, Inc Recent Developments

    Table 141. Novartis AG Company Information

    Table 142. Novartis AG Description and Major Businesses

    Table 143. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 144. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 145. Novartis AG Recent Developments

    Table 146. UCB S.A. Company Information

    Table 147. UCB S.A. Description and Major Businesses

    Table 148. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 149. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 150. UCB S.A. Recent Developments

    Table 151. Key Raw Materials Lists

    Table 152. Raw Materials Key Suppliers Lists

    Table 153. Glutamate Receptor Ionotropic NMDA 2B Distributors List

    Table 154. Glutamate Receptor Ionotropic NMDA 2B Customers List

    Table 155. Glutamate Receptor Ionotropic NMDA 2B Market Trends

    Table 156. Glutamate Receptor Ionotropic NMDA 2B Market Drivers

    Table 157. Glutamate Receptor Ionotropic NMDA 2B Market Challenges

    Table 158. Glutamate Receptor Ionotropic NMDA 2B Market Restraints

    Table 159. Research Programs/Design for This Report

    Table 160. Key Data Information from Secondary Sources

    Table 161. Key Data Information from Primary Sources

List of Figures

    Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Picture

    Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2029

    Figure 4. JNJ-0808 Product Picture

    Figure 5. Neu-2000 Product Picture

    Figure 6. NP-10679 Product Picture

    Figure 7. NP-11948 Product Picture

    Figure 8. Radiprodil Product Picture

    Figure 9. Others Product Picture

    Figure 10. Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 11. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2029

    Figure 12. Acute Ischemic Stroke

    Figure 13. Autism

    Figure 14. Brain Ischemia

    Figure 15. Burns

    Figure 16. Others

    Figure 17. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered

    Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2018-2029 (US$ Million)

    Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2018-2029)

    Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Sales 2018-2029 ((K Pcs)

    Figure 23. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2018-2029)

    Figure 24. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2018-2029) & (K Pcs)

    Figure 25. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue YoY (2018-2029) & (US$ Million)

    Figure 26. Europe Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2018-2029) & (K Pcs)

    Figure 27. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue YoY (2018-2029) & (US$ Million)

    Figure 28. China Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2018-2029) & (K Pcs)

    Figure 29. China Glutamate Receptor Ionotropic NMDA 2B Revenue YoY (2018-2029) & (US$ Million)

    Figure 30. Asia (excluding China) Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2018-2029) & (K Pcs)

    Figure 31. Asia (excluding China) Glutamate Receptor Ionotropic NMDA 2B Revenue YoY (2018-2029) & (US$ Million)

    Figure 32. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales YoY (2018-2029) & (K Pcs)

    Figure 33. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue YoY (2018-2029) & (US$ Million)

    Figure 34. The Glutamate Receptor Ionotropic NMDA 2B Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 35. The Top 5 and 10 Largest Manufacturers of Glutamate Receptor Ionotropic NMDA 2B in the World: Market Share by Glutamate Receptor Ionotropic NMDA 2B Revenue in 2022

    Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 39. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 40. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 41. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 42. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 43. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 44. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 45. US & Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2018-2029)

    Figure 46. US & Canada Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2018-2029)

    Figure 47. U.S. Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 48. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 49. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 50. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 51. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 52. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 53. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2018-2029)

    Figure 54. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2018-2029)

    Figure 55. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 56. France Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 57. U.K. Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 58. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 59. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 60. China Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 61. China Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 62. China Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 63. China Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 64. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 65. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 66. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 67. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 68. Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Region (2018-2029)

    Figure 69. Asia Glutamate Receptor Ionotropic NMDA 2B Sales Share by Region (2018-2029)

    Figure 70. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 71. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 72. China Taiwan Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 73. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 74. India Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 75. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2029)

    Figure 76. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2029)

    Figure 77. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2029)

    Figure 78. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2029)

    Figure 79. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Country (2018-2029)

    Figure 80. Middle East, Africa and Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Share by Country (2018-2029)

    Figure 81. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 82. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 83. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 84. Israel Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 85. GCC Countries Glutamate Receptor Ionotropic NMDA 2B Revenue (2018-2029) & (US$ Million)

    Figure 86. Glutamate Receptor Ionotropic NMDA 2B Value Chain

    Figure 87. Glutamate Receptor Ionotropic NMDA 2B Production Process

    Figure 88. Channels of Distribution

    Figure 89. Distributors Profiles

    Figure 90. Bottom-up and Top-down Approaches for This Report

    Figure 91. Data Triangulation

    Figure 92. Key Executives Interviewed